Success Metrics

Clinical Success Rate

100.0%

Based on 1 completed trials

Completion Rate

100%(1/1)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

67%

Ph phase_1

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(1)

Detailed Status

Completed1

Withdrawn1

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 1

Trials by Phase

Phase 11 (33.3%)

N/A2 (66.7%)

Trials by Status

completed133%

withdrawn133%

not_yet_recruiting133%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Pulse Oximetry Performance Test for PaMo - Controlled Desaturation Test

NCT07676227

not_yet_recruitingnot_applicable

Investigating the Combined Effects of Intermittent Hypoxia and Exercise on Cognitive and Cerebral Function in Middle-Aged Adults

NCT06874387

withdrawnphase_1

PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke

NCT05210088

Clinical Trials (3)

Showing 3 of 3 trials

NCT07676227Not Applicable

Pulse Oximetry Performance Test for PaMo - Controlled Desaturation Test

Completed

NCT06874387Not Applicable

Investigating the Combined Effects of Intermittent Hypoxia and Exercise on Cognitive and Cerebral Function in Middle-Aged Adults

Not Yet Recruiting

NCT05210088Phase 1

PLAsticity, Security and Tolerance to Intermittent Hypoxic Conditioning Following Stroke

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3